Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

There's the final part of The Skinny Jab Revolution, new series Chess Masters: The Endgame, Michael Sheen's Secret Million ...

Discover how peptides are transforming medical treatments, metabolic conditions and more with fewer side effects than ...

Terns Pharmaceuticals is a small-cap biotech with a couple of weight loss candidates in its pipeline. The stock's price ...

The story of one huge advance in health care shows why public investment in science is critical and why proposed cuts are ...

Glp-1s cover a variety of drugs that are commonly used for weight loss, such as Ozempic, Wegovy and Mounjaro. And West Virginians used them at the highest rate ...

Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

On Thursday, Jim Cramer, the host of Mad Money, discussed the recent turbulence in the stock market, pointing to the lack of ...

Stanford researchers have discovered BRP, a naturally occurring peptide that suppresses appetite and promotes weight loss, ...

Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...

On February 21, 2025, the US Food and Drug Administration (FDA) revised its shortage categorization of semaglutide, a glucagon-like peptide 1 ...

Less than a year after cutting coverage of GLP-1 weight loss drugs such as Wegovy, the North Carolina State Health Plan is now asking the legislature to pay for bringing back coverage.